HIV-1 Drug Resistance Mutations Among Antiretroviral-Naive HIV-1-Infected Patients in Asia: Results From the TREAT Asia Studies to Evaluate Resistance-Monitoring Study

被引：40

作者：

Sungkanuparph, Somnuek ^{[1
]}

Oyomopito, Rebecca ^{[7
]}

Sirivichayakul, Sunee ^{[2
,3
]}

Sirisanthana, Thira ^{[5
]}

Li, Patrick C. K. ^{[8
]}

Kantipong, Pacharee ^{[6
]}

Lee, Christopher K. C. ^{[9
]}

Kamarulzaman, Adeeba ^{[10
]}

Messerschmidt, Liesl ^{[4
]}

Law, Matthew G. ^{[7
]}

Phanuphak, Praphan ^{[2
,3
]}

机构：

[1] Mahidol Univ, Ramathibodi Hosp, Fac Med, Bangkok 10400, Thailand

[2] Chulalongkorn Univ, HIV NAT Thai Red Cross AIDS Res Ctr, Bangkok 10330, Thailand

[3] Chulalongkorn Univ, Fac Med, Bangkok 10330, Thailand

[4] TREAT Asia, Fdn AIDS Res, Bangkok, Thailand

[5] Res Inst Hlth Sci, Chiang Mai, Thailand

[6] Chiang Rai Reg Hosp, Chiang Rai, Thailand

[7] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia

[8] Queen Elizabeth Hosp, Hong Kong, Hong Kong, Peoples R China

[9] Hosp Sungai Buloh, Sungai Buloh, Malaysia

[10] Univ Malaya, Kuala Lumpur, Malaysia

来源：

CLINICAL INFECTIOUS DISEASES | 2011年 / 52卷 / 08期

关键词：

REVERSE-TRANSCRIPTASE; INFECTED PATIENTS; GENOTYPIC RESISTANCE; THRESHOLD SURVEY; DUAL-NUCLEOSIDE; THERAPY; PREVALENCE; ZIDOVUDINE; SURVIVAL; STRAINS;

D O I：

10.1093/cid/cir107

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Of 682 antiretroviral-naive patients initiating antiretroviral therapy in a prospective, multicenter human immunodeficiency virus type 1 (HIV-1) drug resistance monitoring study involving 8 sites in Hong Kong, Malaysia, and Thailand, the prevalence of patients with >= 1 drug resistance mutation was 13.8%. Primary HIV drug resistance is emerging after rapid scaling-up of antiretroviral therapy use in Asia.

引用

页码：1053 / 1057

页数：5

共 41 条

[1] Rates of transmission of antiretroviral drug resistant strains of HIV-1
Ammaranond, P
Cunningham, P
Oelrichs, R
Suzuki, K
Harris, C
Leas, L
Grulich, A
Cooper, DA
Kelleher, AD
[J]. JOURNAL OF CLINICAL VIROLOGY, 2003, 26 (02) : 153 - 161
[2] [Anonymous], 2010, Towards universal access: scaling up priority HIV/AIDS interventions in the health sector
[3] Antiretroviral drug resistance among antiretroviral-naive persons with recent HIV infection in Thailand
Apisarnthanarak, A.
Jirayasethpong, T.
Sa-nguansilp, C.
Thongprapai, H.
Kittihanukul, C.
Kamudamas, A.
Tungsathapornpong, A.
Mundy, L. M.
[J]. HIV MEDICINE, 2008, 9 (05) : 322 - 325
[4] Balotta C, 2000, ANTIVIR THER, V5, P7
[5] Prevalence and predictors of antiretroviral drug resistance in newly diagnosed HIV-1 infection
Booth, Clare L.
Garcia-Diaz, Ana M.
Youle, Michael S.
Johnson, Margaret A.
Phillips, Andrew
Geretti, Anna Maria
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (03) : 517 - 524
[6] Césaire R, 1999, J ACQ IMMUN DEF SYND, V22, P401
[7] Corvasce S, 2006, ANTIVIR THER, V11, P329
[8] *CTR INF DIS PREV, HIV 1 STRAIN PRIM DR
[9] Prevalence of genotypic resistance in untreated HIV patients in Spain
Eiros, JM
Labayru, C
Hernández, B
Ortega, M
Bachiller, P
de Lejarazu, RO
[J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2002, 21 (04) : 310 - 313
[10] BRIEF REPORT - PRIMARY INFECTION WITH ZIDOVUDINE-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
ERICE, A
MAYERS, DL
STRIKE, DG
SANNERUD, KJ
MCCUTCHAN, FE
HENRY, K
BALFOUR, HH
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (16) : 1163 - 1165

← 1 2 3 4 5 →